Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
about
Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)Orbital lymphoma: role of radiation.Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patientsOrbital lymphoma: diagnostic approach and treatment outcome.Therapeutic management of ocular adnexal MALT lymphoma.A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphomaExtranodal marginal zone lymphoma of the ocular adnexaOcular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.Frontline treatment with chemoimmunotherapy for limited-stage ocular adnexal MALT lymphoma with adverse factors: a phase II studyTreatment outcome and risk analysis for cataract after radiotherapy of localized ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma.Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function.Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).Orbital and ocular adnexal Mucosa-Associated Lymphoid Tissue (MALT) lymphomas: a single-center 10-year experience.Cataracts after Low-Dose Radiotherapy for Lymphoproliferative Disease of the Ocular Adnexa.Extranodal Marginal Zone Lymphoma of Ocular Adnexa: Outcomes following Radiation Therapy.Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.The clinical features of radiation cataract in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
P2860
Q26771654-A120E5AE-8BD6-4DBA-BE0F-F7883C9EAC0CQ33411716-7B51523D-76E8-4CDA-AD28-3396F3871B3DQ34789238-BB110593-3C1E-4E0B-B180-D6C9DDA24742Q36741218-687B0872-F793-4163-957F-5188B787A9B3Q36964741-78BD67F3-E08E-4802-9C36-EE4FCE0EB287Q37038505-865958A7-3CC3-49EF-AC57-6565F712406CQ37268954-B763BB98-1653-44E0-9A33-52907F17E10AQ41995034-1A1F0835-739F-4333-B10A-2F53306C1375Q42366631-668812C5-8784-48E3-BC5C-F482A527E013Q42380320-18AF0DC0-5CE8-443B-899E-761B07711130Q42514965-D47C4EB6-C97A-4A2C-8448-6696EB0D6C7EQ42926720-E35A135C-8EF7-4CD8-859A-8368AC1AB508Q43573759-666CE8ED-933D-415F-BD89-78A198EEC245Q43738468-2C7B08CA-6C45-4800-8E3D-B98D4D3F4074Q48157931-4F69B97D-0702-496F-8E7C-00FDA0ACDE97Q50040751-E897FB5F-F25E-4747-B228-AC276E1E6CE2Q51605001-7F22C5C6-1391-4F8B-983B-66CED987C66AQ53049966-996DD049-FF8C-4BB6-B061-29B427A6A5C4Q55098766-8BF93562-ACD4-4456-9693-6BCACC473213
P2860
Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
@en
Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
@nl
type
label
Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
@en
Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
@nl
prefLabel
Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
@en
Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
@nl
P2093
P1476
Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
@en
P2093
Atsushi Azumi
Kazuro Sugimura
Ryohei Sasaki
Toshinori Soejima
Tsutomu Maruta
Yoshiaki Okamoto
Yoshitake Hayashi
Yosuke Ota
Yusuke Demizu
P356
10.1016/J.RADONC.2005.11.005
P50
P577
2005-12-15T00:00:00Z